Bisphosphonates (Fosamax) Increases Risk of Femoral Fractures

A recent article in the Journal of the American Medical Association (JAMA) has again linked use of bisphosphonates for osteoporosis to increased risk of subtrochanteric and femur fractures.  The drugs in the bisphosphonate family include Fosamax, Boniva, Actonel, Aredia, Zometa, and Reclast. The JAMA article, entitled "Bisphosphonate Use and the Risk of Subtrochanteric and Femoral [...]